Document is current
Any future updates will be listed below
-
Authors
Leppä, Aino-Maija https://orcid.org/0000-0003-0849-1759
Grimes, Karen https://orcid.org/0000-0002-4805-2366
Jeong, Hyobin https://orcid.org/0000-0002-1526-3343
Huang, Frank Y. https://orcid.org/0000-0002-2163-9300
Andrades, Alvaro
Waclawiczek, Alexander
Boch, Tobias
Jauch, Anna
Renders, Simon
Stelmach, Patrick https://orcid.org/0009-0000-5270-4761
Müller-Tidow, Carsten https://orcid.org/0000-0002-7166-5232
Karpova, Darja
Sohn, Markus
Grünschläger, Florian
Hasenfeld, Patrick
Benito Garagorri, Eva
Thiel, Vera
Dolnik, Anna https://orcid.org/0000-0003-4166-2900
Rodriguez-Martin, Bernardo
Bullinger, Lars https://orcid.org/0000-0002-5890-5510
Mrózek, Krzysztof https://orcid.org/0000-0002-1408-5063
Eisfeld, Ann-Kathrin https://orcid.org/0000-0001-6442-1419
Krämer, Alwin
Sanders, Ashley D. https://orcid.org/0000-0003-3945-0677
Korbel, Jan O. https://orcid.org/0000-0002-2798-3794
Trumpp, Andreas https://orcid.org/0000-0002-6212-3466
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 15 October 2024
First Online: 25 November 2024
Competing interests
: A.D.S. and J.O.K. have previously disclosed a patent application (no. EP19169090) that is relevant to this manuscript. A.K.E. received an honorarium from AstraZeneca for serving on their diversity, equity and inclusion advisory board, and her spouse has ownership interest and is employed by Karyopharm Therapeutics. The remaining authors declare no competing interests.
